Frequency of PIK3CA mutations in HER2+surgically resected breast cancers in a Hispanic cohort

被引：0
|
作者：
Munive, Carlos
Gallo, Aly
Neciosup, Silvia P.
Doimi, Franco
Dyer, Richard
Pinto, Joseph
Lopez-Ilasaca, Marco
Gomez, Henry
机构：
[1] Inst Nacl Enfermedades Neoplas, Lima, Peru
[2] Ctr Mol Diagnost, Lima, Peru
[3] Oncosalud, Lima, Peru
[4] Harvard Univ, Sch Med, Brigham & Womens Hosp, Lima, Peru
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11066
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Concordance between PIK3CA mutations in endoscopic biopsy and surgically resected specimens of esophageal squamous cell carcinoma
    Hatogai, Ken
    Fujii, Satoshi
    Kojima, Takashi
    Daiko, Hiroyuki
    Doi, Toshihiko
    Ohtsu, Atsushi
    Ochiai, Atsushi
    Takiguchi, Yuichi
    Yoshino, Takayuki
    BMC CANCER, 2017, 17
  • [22] Concordance between PIK3CA mutations in endoscopic biopsy and surgically resected specimens of esophageal squamous cell carcinoma
    Ken Hatogai
    Satoshi Fujii
    Takashi Kojima
    Hiroyuki Daiko
    Toshihiko Doi
    Atsushi Ohtsu
    Atsushi Ochiai
    Yuichi Takiguchi
    Takayuki Yoshino
    BMC Cancer, 17
  • [23] PIK3CA mutations in primary HER2-positive and triple negative breast cancer.
    Loibl, Sibylle
    Denkert, Carsten
    Loi, Sherene
    Andre, Fabrice
    Mueller, Berit
    Schneeweiss, Andreas
    Blohmer, Jens U.
    Jackisch, Christian
    Guo Sanxing
    Gade, Stephan
    Fasching, Peter A.
    Schem, Christian
    Sotiriou, Christos
    Untch, Michael
    Von Minckwitz, Gunter
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] PIK3CA and APC mutations are synergistic in the development of intestinal cancers
    D A Deming
    A A Leystra
    L Nettekoven
    C Sievers
    D Miller
    M Middlebrooks
    L Clipson
    D Albrecht
    J Bacher
    M K Washington
    J Weichert
    R B Halberg
    Oncogene, 2014, 33 : 2245 - 2254
  • [25] PIK3CA and APC mutations are synergistic in the development of intestinal cancers
    Deming, D. A.
    Leystra, A. A.
    Nettekoven, L.
    Sievers, C.
    Miller, D.
    Middlebrooks, M.
    Clipson, L.
    Albrecht, D.
    Bacher, J.
    Washington, M. K.
    Weichert, J.
    Halberg, R. B.
    ONCOGENE, 2014, 33 (17) : 2245 - 2254
  • [26] Frequency of PIK3CA Mutations and Therapeutic Outcomes in NSCLC
    Martos, G.
    Bebb, G.
    Pabani, A.
    Gibson, A.
    Dean, M.
    Petersen, L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1161 - S1162
  • [27] Decreased PTEN expression and PIK3CA mutations in HER-2 positive breast cancer.
    Koninki, K.
    Kauraniemi, P.
    Pitkanen, J.
    Isola, J.
    Tanner, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S211 - S211
  • [28] PIK3CA Mutations in In situ and Invasive Breast Carcinomas
    Miron, Alexander
    Varadi, Maria
    Carrasco, Daniel
    Li, Hailun
    Luongo, Lauren
    Kim, Hee Jung
    Park, So Yeon
    Cho, Eun Yoon
    Lewis, Gretchen
    Kehoe, Sarah
    Iglehart, J. Dirk
    Dillon, Deborah
    Allred, D. Craig
    Macconaill, Laura
    Gelman, Rebecca
    Polyak, Kornelia
    CANCER RESEARCH, 2010, 70 (14) : 5674 - 5678
  • [29] PIK3CA mutations in breast cancer: A Tunisian series
    Ben Rekaya, Mariem
    Sassi, Farah
    Saied, Essya
    Kacem, Linda Bel Haj
    Mansouri, Nada
    Zarrouk, Sinda
    Azouz, Saifeddine
    Rammeh, Soumaya
    PLOS ONE, 2023, 18 (05):
  • [30] Analysis of PIK3CA Mutations in Breast Cancer Subtypes
    Arsenic, Ruza
    Lehmann, Annika
    Budczies, Jan
    Koch, Ines
    Prinzler, Judith
    Kleine-Tebbe, Anke
    Schewe, Christiane
    Loibl, Sibylle
    Dietel, Manfred
    Denkert, Carsten
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2014, 22 (01) : 50 - 56
12345